Back to search
KERATOCONJUNCTIVITIS SICCA
Clinical trial pipeline · Data from ClinicalTrials.gov
See which KERATOCONJUNCTIVITIS SICCA trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which KERATOCONJUNCTIVITIS SICCA trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Background: Sjogren disease is an autoimmune disease - that is, a disease that causes the body's immune system to attack its own organs and tissues. Sjogren di…
This is a Phase 2, randomized, multicenter, double masked, vehicle controlled, parallel group study to evaluate the efficacy and safety of DFL24498 topical opht…
The objectif is to study the diagnosis performance of the different classification criteria in reference to the gold standard consisting of the diagnosis made b…
Background: \- Salivary glands in and around the mouth and throat make saliva. Salivary gland disorders can affect a person s quality of life. Studying people…
Clinical trial aims to determine the optimal dosing regimen by evaluating the efficacy and safety of HUC1-394 across different dosing frequencies in patients wi…
Compare eye dryness following laser-assisted in situ keratomileusis (LASIK) surgery to eye dryness prior to receiving perioperative Miebo in patients with dry e…
Sjögren's syndrome is a condition in which the immune system attacks the body's moisture-producing glands. This often causes severe dry eye, leading to discomfo…
Drug delivery platforms are an innovative exciting advancement in ophthalmology. They allow patients to eliminate topical medications which are generally associ…